|
WAC expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.348040E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.891200E-01 |
| Normal-vs-Stage2 |
6.538400E-01 |
| Normal-vs-Stage3 |
2.395900E-04 |
| Normal-vs-Stage4 |
2.244600E-04 |
| Stage1-vs-Stage2 |
2.595200E-01 |
| Stage1-vs-Stage3 |
2.9271000000497E-06 |
| Stage1-vs-Stage4 |
1.81830000000049E-05 |
| Stage2-vs-Stage3 |
5.999900E-02 |
| Stage2-vs-Stage4 |
3.866100E-02 |
| Stage3-vs-Stage4 |
7.031200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.977170E-01 |
| Normal-vs-AfricanAmerican |
2.360000E-02 |
| Normal-vs-Asian |
5.532200E-01 |
| Caucasian-vs-AfricanAmerican |
1.560010E-01 |
| Caucasian-vs-Asian |
3.586600E-01 |
| AfricanAmerican-vs-Asian |
1.140210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.282400E-02 |
| Normal-vs-Female |
6.514400E-01 |
| Male-vs-Female |
1.981220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.619200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.268000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.862200E-02 |
| Normal-vs-Age(81-100Yrs) |
6.709400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.195400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.527400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.428000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.147700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.454200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.095200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.047500E-02 |
| Normal-vs-Grade 2 |
2.029400E-01 |
| Normal-vs-Grade 3 |
1.002100E-02 |
| Normal-vs-Grade 4 |
4.58030000038967E-07 |
| Grade 1-vs-Grade 2 |
3.795600E-02 |
| Grade 1-vs-Grade 3 |
2.969200E-04 |
| Grade 1-vs-Grade 4 |
6.20639999948658E-07 |
| Grade 2-vs-Grade 3 |
1.176790E-04 |
| Grade 2-vs-Grade 4 |
1.81029999879456E-08 |
| Grade 3-vs-Grade 4 |
2.859200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.223700E-04 |
| Normal-vs-ccB subtype |
7.95609999992841E-07 |
| ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.214000E-01 |
| Normal-vs-N1 |
3.793900E-02 |
| N0-vs-N1 |
1.523390E-01 |
|
|
